King & Wood Mallesons (KWM) has advised KKR on its acquisition of a minority stake in healthcare provider GenesisCare.
The investment is being made through KKR's Core Investments strategy, which has a long-term mandate and will see KKR's ownership sit alongside China Resources Group, who will hold a continuing stake following a sell down by China Resources Group and Macquarie, and doctor and management shareholders.
The KWM deal team was led by partners Ros Anderson, Mark McNamara and Tim Sherman, who were supported by special counsel Mandy Tsang, senior associates Alexander Galanos, Victoria Lanyon and solicitors Claire Achermann, Justin Wretham.
Commenting of the deal Ros Anderson said: "We are pleased to have worked with our long-standing client to once again take an ownership stake in this global healthcare provider."
KKR's investment provides new funding for GenesisCare's expansion plans, which include rolling out 35 new sites in Australia, Europe and also China.
The move signifies a return to GenesisCare for KKR, who purchased a 45 per cent stake in 2012, before selling to China Resources Group and Macquarie Capital in 2016.
Last year, KWM advised KKR Credit on its public to private acquisition of Pepper Group.
